CureVac NV (5CV)

81.62
+0.27(+0.33%)
  • Volume:
    12,011
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    81.00 - 82.98

5CV Overview

Prev. Close
81.35
Day's Range
81-82.98
Revenue
14.32M
Open
82
52 wk Range
35.5-125.44
EPS
-
Volume
12,011
Market Cap
-
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
41,603
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
-
Next Earnings Date
Sep 01, 2021
What is your sentiment on CureVac NV?
or
Market is currently closed. Voting is open during market hours.

CureVac NV News

CureVac NV Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

CureVac NV Company Profile

CureVac NV Company Profile

Employees
500

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Read More
  • From the Motley Fool Germany. Just use Google Translate. https://www.onvista.de/news/curevac-aktie-trader-druecken-den-kurs-fuer-eine-interesssante-langfristige-einstiegschance-464032327
    0
    • soon 90..
      1
      • not today
        0
    • What happens in pre?
      0
      • https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.html
        0
        • thanks
          0
      • huge drop today, any news that cause this ?
        0
        • approval is 2 month postponed
          0
      • what happened?
        0
        • https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.htmlThe European Medicines Agency (EMA) does not expect to make a decision on the approval of German biotech group CureVac's COVID-19 vaccine before August, an off...
          0
      • Approval...this week???
        2
        • I hope so.... 🤞
          0
      • Greatings from Germany. I guess it is a matter of days until we see the next move. As soon as we get some news in, the stock will follow the valuations of Moderna and Biontech (in your country you say Pfizer for the vaccine, but in realty it is Biontech.Alsdo German. The valuation of Biontech is 2,3 times higher and Curevac has the same product as well a a very famous shareholder . At the End of the year we will see the same valutaion for both. My guess is arround 80-100 billion. Best
        1
        • Thanks...I really hope you are right!
          0
        • But the vaccine market is saturated now with the West nearly half vaccinated already.
          0
        • Hope so. It is a solid company with a solid product (mRNA). Essentially same stuff as Biontech and Moderna. nice to meet you, dear neighbour.
          0
      • New Highs on way
        0
        • after this resistance the way look's clean
          0
      • "Changes to international intellectual property rules require unanimous agreement" (...) ""The activists said a waiver alone would not increase the world’s vaccine supply. It must be accompanied by a process known as “tech transfer,” in which patent holders supply technical know-how and personnel." (...) “Handing needy countries a recipe book without the ingredients, safeguards and sizable work force needed will not help people waiting for the vaccine,” Dr. Michelle McMurry-Heath." (NYTIMES) I don't see that happening TBH. Just hard to imagine the cake will be shared or maybe I'm too cynical for this level of humanitarianism. Looking for a dip. What do you think?
        1
        • is there a price action towards to correction of 20% from 130.50 now?
          2
          • Biden killed vaccines related stocks with his his nonsense patent talk
            1
          • Elliot AldersonHe's 140 years old, not enough time to mandate anything. Yeah, I know, I couldn't resist
            1
        • Pop pop
          1
          • Are earnings tommorrow? There are different dates lying around. Cheers.
            0
            • Hi, Giuseppe. It's a secret, and we are not allowed to reveal any info.
              0
            • Schizophrenia plus trading must be fun
              0
          • Buy buy 150 + coming
            1
            • Why Zolex Zoka?
              0
              • World no longer belive in AZN and JNJ ,and on the other side world needs more and more vaccines. CureVac already signed charging contract with Bayer,Sanofi, Novartis ...etc. They will produce most vaccines. I said too low price 150$ ,when they come out from phase III. it will be rocket ,see you then ;-)
                0
              • Ok its true. I’m in, with 200 shares
                0
              • ARCT is more or less the same?!
                0
            • on June 1st 2021. price will hit 150 $ :-)
              1
              • It will fly. Just buy
                1
                • Best stock ever . If ya know how to trade
                  3
                  • Worst stock ever
                    5
                    • Buy buy buy
                      1
                      • Target hit . Next 200
                        1
                        • TP150
                          0
                          • TP 95
                            1
                            • Partnership with Tesla is good news during this dip.
                              0
                              • https://www.google.com.sg/amp/s/www.businesstimes.com.sg/consumer/novartis-deal-bolsters-curevacs-vaccine-contractor-line-up?amp
                                0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.